IP Library Granted Patent US 8,778,678
Granted Patent B2
US 8,778,678 · App. 12/887,054 · Granted Jul 15, 2014

Composition of activated CD4 cells

Inventor: Michael Har-Noy (Jerusalem, IL)
Assignee: Immunovative Therapies Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,778,678
App. No.
12/887,054
Granted
Jul 15, 2014
Kind
B2
Abstract

The composition of activated CD4 cells is derived from a healthy human donor. The composition from the healthy human donor is suspended in an infusion media and packaged in a vehicle for administration to a subject to treat disease.

Claims (8)

1. A composition of activated CD4 cells derived from a healthy human donor suspended in infusion media and packaged in a vehicle for administration to a subject to treat disease.

2. The composition of claim 1 where the CD4 cells are Th1 cells.

3. The composition of claim 1 wherein the CD4 cells are activated by crosslinking of CD3 and CD28.

4. The composition of claim 3 wherein the CD3 and CD28 cross linking is accomplished by using immobilized anti-CD3 and anti-CD28 mAbs.

5. The composition of claim 4 wherein the anti-CD3 and anti-CD28 mAbs are immobilized on nano- or micro-particles.

6. The composition of claim 5 wherein the nano- or micro particles are biodegradable.

7. The composition of claim 1 wherein the anti-CD3 and anti-CD28 mAbs are immobilized on particles less than 1 micron.

8. The composition of claim 7 wherein the particles are biodegradable.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE ADDRESS OS THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 050489 FRAME: 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM IMMUNOVATIVE THERAPIES, LTD. TO MICHAEL HAR-NOY ON THE ORIGINAL COVER SHEET PREVIOUSLY RECORDED ON REEL 050489 FRAME 0245. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
RESCISSION Recorded Sep 12, 2019
From: HAR-NOY, MICHAEL
To: HAR-NOY, MICHAEL
Reel/Frame 050467/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2010
From: HAR-NOY, MICHAEL
To: IMMUNOVATIVE THERAPIES LTD.
Reel/Frame 025085/0663 →
Continuity (8)
Continuation 12173330 · Jul 15, 2008
Division 11069010 · Mar 1, 2005
Continuation In Part 10838454 · May 4, 2004
Provisional Application 60549032 · Mar 1, 2004
Provisional Application 60547966 · Feb 26, 2004
Provisional Application 60545450 · Feb 18, 2004
Provisional Application 60470171 · May 13, 2003
Related Publication 20110033435A1 · Feb 10, 2011